1. Market Research
  2. > Pharmaceutical Market Trends
  3. > 2015 Deep Research Report on Global Active Pharmaceutical Ingredients Industry

Summary

2015 Deep Research Report on Global Active Pharmaceutical Ingredients Industry is a professional and deep research report on Global Active Pharmaceutical Ingredients industry.

For overview analysis, the report introduces Active Pharmaceutical Ingredients basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

For international and China market analysis, the report analyzes Active Pharmaceutical Ingredients markets in China and other countries or regions (such as China, India, Europe, USA etc) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2010-2015 capacity, production, cost, price, Gross, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, Gross, production value, and gross margin for these markets are also included.

For technical data and manufacturing plants analysis, the report analyzes Active Pharmaceutical Ingredients leading suppliers on capacity, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.

This report also presents product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.

In the end, the report includes Active Pharmaceutical Ingredients new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Active Pharmaceutical Ingredients industry. Here, we express our thanks for the support and assistance from Active Pharmaceutical Ingredients industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

Table Of Contents

2015 Deep Research Report on Global Active Pharmaceutical Ingredients Industry
Table of Contents

Chapter One Active Pharmaceutical Ingredients Industry Overview 1
1.1 Active Pharmaceutical Ingredients Definition 1
1.2 Active Pharmaceutical Ingredients Classification 1
1.2.1 Vitamin 2
1.2.2 Antibiotic 3
1.2.3 Antipyretic and Analgesic Activities 3
1.2.4 Hormone 3
1.2.5 Amino Acid 3
1.2.6 Cardiovascular 3
1.2.7 Market Share by Product Type 4
1.3 USA 5
1.3.1 USA Active Pharmaceutical Ingredients Market Development History 5
1.3.2 USA Active Pharmaceutical Import And Export Analysis 5
1.3.3 USA Active Pharmaceutical Market share Analysis 6
1.3.4 USA FDA (DMF) Standard 6
1.4 Italy 7
1.4.1 Italy Active Pharmaceutical Ingredients Market Development History 7
1.4.2 Italy Active Pharmaceutical Import And Export Analysis 8
1.4.3 Italy Active Pharmaceutical Market Share Analysis 8
1.4.4 Italy COS Standard 8
1.5 India 10
1.4.1 India Active Pharmaceutical Ingredients Market Development History 10
1.4.2 India Active Pharmaceutical Import And Export Analysis 10
1.4.3 India Active Pharmaceutical Market share Analysis 11
1.5 Other Region 11
1.5.1 South Korea 11
1.5.2 UK 11
1.5.3 Brazil 11
1.5.4 Japan 12
1.6 Active Pharmaceutical Ingredients Industry News Analysis 12
Chapter Two China Active Pharmaceutical Ingredients Industry 14
2.1 China Active Pharmaceutical Ingredients Environment History and Prediction 14
2.1.1 International Market Environment For Chinese Active Pharmaceutical Ingredients Companies 14
2.1.2 China Active Pharmaceutical Ingredients Market Development History 14
2.1.3 China Active Pharmaceutical Ingredients Technology Development History 15
2.1.4 China Active Pharmaceutical Market share Analysis 15
2.2 The Analysis for China Active Pharmaceutical Ingredients Industry Overview 16
2.2.1 China production Capacity and Capacity Utilization 16
2.2.2 China Major Manufacturers Price 19
2.2.3 China Pharmaceutical Ingredients Production Consumption and Overplus 19
Chapter Three the Problems China Active Pharmaceutical Ingredient Industry Faced 20
3.1 China Active Pharmaceutical Ingredients Industries major Problems 20
3.2 China Active Pharmaceutical Ingredients Industries development Challenges 20
Chapter Four China Active Pharmaceutical Ingredients Marketing Channel 21
4.1 China Active Pharmaceutical Ingredients Marketing Channels Status 21
4.2 China Active Pharmaceutical Ingredients Marketing Channel Environment after New GMP Standard 21
4.3 China Active Pharmaceutical Ingredients Marketing Channel Environment After health care reform 22
Chapter Five Active Pharmaceutical Ingredients Technical Data and Manufacturing Plants Analysis 24
5.1 2014 Global Key Manufacturers Active Pharmaceutical Ingredients Capacity 24
5.2 2014 Global Key Manufacturers Active Pharmaceutical Ingredients Manufacturing Plants Distribution 25
5.3 2014 Global Key Manufacturers Active Pharmaceutical Ingredients RandD Status and Technology Sources 26
Chapter Six Active Pharmaceutical Ingredients Production by Regions By Technology By Applications 28
6.1 2010-2015 Active Pharmaceutical Ingredients Production (Ton) by Countries (such as USA, India, China) 28
6.2 2010-2015 Active Pharmaceutical Ingredients Production (Ton) by Product Type 29
6.3 2010-2015 Active Pharmaceutical Ingredients Price (USD/Ton) by key Manufacturers 29
6.4 2010-2015 US Active Pharmaceutical Ingredients Capacity (Ton) Production Price (USD/Ton) Cost Production Value (Million USD) Analysis 30
6.5 2010-2015 India Active Pharmaceutical Ingredients Capacity (Ton) Production Price (USD/Ton) Cost Production Value (Million USD) Analysis 31
6.4 2010-2015 Italy Active Pharmaceutical Ingredients Capacity (Ton) Production Price (USD/Ton) Cost Production Value (Million USD) Analysis 31
Chapter Seven 2010-2015 Active Pharmaceutical Ingredients Productions Supply Sales Market Status and Forecast 32
7.1 2010-2015 Active Pharmaceutical Ingredients Capacity Production Overview 32
7.2 2010-2015 Active Pharmaceutical Ingredients Production Market Share Analysis 37
7.3 2010-2015E Active Pharmaceutical Ingredients Consumption Overview 42
7.4 2010-2015E Active Pharmaceutical Ingredients Cost Price Production Value Gross Margin 42
Chapter Eight Active Pharmaceutical Ingredients Key Manufacturers Analysis 53
8.1 TEVA 53
8.1.1 Company Profile 53
8.1.2 Capacity Production Price Cost Production Value 54
8.1.3 Contact Information 56
8.2 DSM 56
8.2.1 Company Profile 56
8.2.2 Capacity Production Price Cost Production Value 57
8.2.3 Contact Information 58
8.3 Novartis 59
8.3.1 Company Profile 59
8.3.2 Capacity Production Price Cost Production Value 60
8.3.3 Contact Information 61
8.4 Roche 62
8.4.1 Company Profile 62
8.4.2 Capacity Production Price Cost Production Value 63
8.4.3 Contact Information 65
8.5 Johnson and Johnson 65
8.5.1 Company Profile 65
8.5.2 Capacity Production Price Cost Production Value 67
8.5.3 Contact Information 68
8.6 Dr. Reddy's Laboratories 68
8.6.1 Company Profile 68
8.6.2 Capacity Production Price Cost Production Value 69
8.6.3 Contact Information 71
8.7 Pfizer 71
8.7.1 Company Profile 71
8.7.2 Capacity Production Price Cost Production Value 72
8.7.3 Contact Information 73
8.8 Bayer 74
8.8.1 Company Profile 74
8.8.2 Capacity Production Price Cost Production Value 75
8.8.3 Contact Information 76
8.9 BASF 76
8.9.1 Company Profile 77
8.9.2 Capacity Production Price Cost Production Value 77
8.9.3 Contact Information 79
8.10 Cambrex 79
8.10.1 Company Profile 80
8.10.2 Capacity Production Price Cost Production Value 80
8.10.3 Contact Information 81
8.11 Sun Pharmaceutical 82
8.11.1 Company Profile 82
8.11.2 Capacity Production Price Cost Production Value 83
8.11.3 Contact Information 85
8.12 Lonza group 85
8.12.1 Company Profile 85
8.12.2 Capacity Production Price Cost Production Value 86
8.12.3 Contact Information 87
8.13 Boehringer Ingelheim GmbH 87
8.13.1 Company Profile 87
8.13.2 Capacity Production Price Cost Production Value 88
8.13.3 Contact Information 89
8.14 Aurobindo pharma 89
8.14.1 Company Profile 89
8.14.2 Capacity Production Price Cost Production Value 90
8.14.3 Contact Information 92
8.15 Lupin 92
8.15.1 Company Profile 92
8.15.2 Capacity Production Price Cost Production Value 93
8.15.3 Contact Information 94
8.16 Biocon 94
8.16.1 Company Profile 95
8.16.2 Capacity Production Price Cost Production Value 96
8.16.3 Contact Information 97
8.17 Cipla 98
8.17.1 Company Profile 98
8.17.2 Capacity Production Price Cost Production Value 99
8.17.3 Contact Information 100
8.18 Hisun Pharmacy 100
8.18.1 Company Profile 100
8.18.2 Capacity Production Price Cost Production Value 101
8.18.3 Contact Information 103
8.19 Huahai Pharmaceutical 103
8.19.1 Company Profile 103
8.19.2 Capacity Production Price Cost Production Value 104
8.19.3 Contact Information 105
8.20 North China Pharmaceutical Group 105
8.20.1 Company Profile 105
8.20.2 Capacity Production Price Cost Production Value 106
8.20.3 Contact Information 107
8.21 Lukang Pharmaceutical 108
8.21.1 Company Profile 108
8.21.2 Capacity Production Price Cost Production Value 109
8.21.3 Contact Information 110
8.22 Haerbin Pharmaceutical 110
8.22.1 Company Profile 110
8.22.2 Capacity Production Price Cost Production Value 112
8.22.3 Contact Information 114
8.23 Xinhua Pharmaceutical 114
8.23.1 Company Profile 114
8.23.2 Capacity Production Price Cost Production Value 115
8.23.3 Contact Information 116
8.24 Jiangsu?Hengrui Medicine 117
8.24.1 Company Profile 117
8.24.2 Capacity Production Price Cost Production Value 117
8.24.3 Contact Information 119
8.25 Tian Yao 119
8.25.1 Company Profile 119
8.25.2 Capacity Production Price Cost Production Value 120
8.25.3 Contact Information 121
8.26 North East Pharmaceutical 121
8.26.1 Company Profile 122
8.26.2 Capacity Production Price Cost Production Value 122
8.26.3 Contact Information 124
8.27 Zhejiang Medicine 124
8.27.1 Company Profile 124
8.27.2 Capacity Production Price Cost Production Value 125
8.27.3 Contact Information 127
Chapter Nine Major Manufacturers Price Gross Margin Analysis 128
9.1 Price and Supply Consumption Analysis 128
9.2 Gross Margin Analysis 129
9.3 Regional Price Comparison Analysis 130
9.4 Different Type Market Analysis 130
Chapter Ten 2015-2020 Active Pharmaceutical Ingredients Productions Supply Sales Consumption Market Status and Forecast 131
10.1 2015-2020 Active Pharmaceutical Ingredients Capacity Production Overview 131
10.2 2015-2020 Active Pharmaceutical Ingredients Consumption Overview 133
10.3 2015-2020 Active Pharmaceutical Ingredients Cost Price Production Value Gross Margin 134
Chapter Eleven Active Pharmaceutical Ingredients Industry Chain and Contact Information Analysis 135
11.1 Manufacturing Equipment Suppliers and Contact Information 135
11.2 Key Buyers (Consumers) and Their Contact Information 136
11.3 Active Pharmaceutical Ingredients Supply Chain Relationship Analysis 137
Chapter Twelve Active Pharmaceutical Ingredients New Project Investment Feasibility Analysis 138
12.1 Active Pharmaceutical Ingredients Project SWOT Analysis 138
12.2 Active Pharmaceutical Ingredients New Project Investment Feasibility Analysis 139
12.2.1 Project Name 139
12.2.2 Investment Budget 139
Chapter Thirteen Global Active Pharmaceutical Ingredients Industry Research Conclusions 139



Tables and Figures

Figure Active Pharmaceutical Ingredients 1
Table API Classifications by Applications 2
2014 Market Share by Product Type 4
Figure USA Active Pharmaceutical Ingredients Market Development History 5
Table 2010-2015E USA Active Pharmaceutical Production Import Export Consumption (Ton) 5
Figure 2010-2015E USA Active Pharmaceutical Market share 6
Table 2010-2015E Italy Active Pharmaceutical Production Import Export Consumption (Ton) 8
Figure 2010-2015E Italy Active Pharmaceutical Market share 8
Table 2010-2015E India Active Pharmaceutical Production Import Export Consumption (Ton) 10
Figure 2010-2015E India Active Pharmaceutical Market share 11
Figure China Active Pharmaceutical Market share 15
Table 2010-2015E China Major Manufacturers Active Pharmaceutical Ingredients Capacity and Total Capacity (Ton) List 16
Table 2010-2015E China Major Manufacturers Active Pharmaceutical Ingredients Capacity Market Share List 16
Table 2010-2015E China Major Manufacturers Active Pharmaceutical Ingredients Production and Total Production (Ton) List 17
Table 2010-2015E China Major Manufacturers Active Pharmaceutical Ingredients Production Market Share List 17
Figure 2010-2015E China Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 18
Figure 2010-2015E China Active Pharmaceutical Ingredients Capacity Production Capacity Utilization Rate List 18
Figure China Major Manufacturers Price 19
China Pharmaceutical Ingredients Production Consumption and Overplus 19
Figure Active Pharmaceutical Ingredients Marketing Channels Status 21
Table 2014 Global Active Pharmaceutical Ingredients Key Manufacturers Capacity (Ton) 24
Table Global Key Manufacturers Active Pharmaceutical Ingredients Plants Distribution 25
Table 2014 Global Key Manufacturers Active Pharmaceutical Ingredients Technology List 26
Table USA 2010-2015 Production, Capacity, Capacity utilization 28
Table India 2010-2015 Production Capacity, Capacity ultilizaztion 28
Table Italy 2010-2015 Production Capacity, Capacity ultilizaztion 28
Table 2010-2015 Active Pharmaceutical Ingredients Production By Product Type 29
Table 2010-2015 Active Pharmaceutical Ingredients Price By Key Manufacturers 29
Table USA Active Pharmaceutical Ingredients Capacity Production Price Cost Production Value 30
Table India Active Pharmaceutical Ingredients Capacity Production Price Cost Production Value 31
Table Italy Active Pharmaceutical Ingredients Capacity Production Price Cost Production Value 31
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Capacity and Total Capacity (Ton) List 32
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Capacity Market Share List 33
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Production and Total Production (Ton) List 34
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Production Market Share List 34
Figure 2010-2015E Global Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 36
Figure 2010 Global Major Manufacturers Active Pharmaceutical Ingredients Production Market Share 37
Figure 2011 Global Major Manufacturers Active Pharmaceutical Ingredients Production Market Share 38
Figure 2012 Global Major Manufacturers Active Pharmaceutical Ingredients Production Market Share 39
Figure 2013 Global Major Manufacturers Active Pharmaceutical IngredientsProduction Market Share 40
Figure 2014 Global Major Manufacturers Active Pharmaceutical Ingredients Production Market Share 41
Figure 2010-2015E Global Active Pharmaceutical Ingredients Consumption (Ton) and Growth Rate 42
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Price (USD/Ton) List 42
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Gross Margin List 43
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Production Value (Million USD) List 44
Table 2010-2015E Global Major Manufacturers Active Pharmaceutical Ingredients Production Value market share List 45
Figure 2010 Global Major Manufacturers Active Pharmaceutical Ingredients Production Value Market Share 46
Figure 2011 Global Major Manufacturers Active Pharmaceutical Value Market Share 47
Figure 2012 Global Major Manufacturers Active Pharmaceutical Ingredients Production Value Market Share 48
Figure 2013 Global Major Manufacturers Active Pharmaceutical Ingredients Production Value Market Share 50
Figure 2014 Global Major Manufacturers Active Pharmaceutical Ingredients Production Value Market Share 51
Table 2010-2015E Global Active Pharmaceutical Ingredients Production (Ton) Price Cost Gross (USD/Ton) Production Value (Million USD) Gross Margin List 52
Table TEVA Company Profile 53
Table 2010-2015 TEVA Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 54
Figure 2010-2015 TEVA Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 55
Figure 2010-2015 TEVA Active Pharmaceutical Ingredients Production Global Market Share 55
Table DSM Company Profile 56
Table 2010-2015 DSM Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 57
Figure 2010-2015 DSM Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 58
Figure 2010-2015 DSM Active Pharmaceutical Ingredients Production Global Market Share 58
Table Novartis Company Profile 59
Table 2010-2015 Novartis Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 60
Figure 2010-2015 Novartis Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 61
Figure 2010-2015 Novartis Active Pharmaceutical Ingredients Production Global Market Share 61
Table Roche Company Profile 62
Table 2010-2015 Roche Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 63
Figure 2010-2015 Roche Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 64
Figure 2010-2015 Roche Active Pharmaceutical Ingredients Production Global Market Share 64
Table Johnson and Johnson Company Profile 65
Table 2010-2015 Johnson and Johnson Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 67
Figure 2010-2015 Johnson and Johnson Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 67
Figure 2010-2015 Johnson and Johnson Active Pharmaceutical Ingredients Production Global Market Share 68
Table Dr. Reddy's Laboratories Company Profile 69
Table 2010-2015 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 69
Figure 2010-2015 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 70
Figure 2010-2015 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients Production Global Market Share 70
Table Pfizer Company Profile 71
Table 2010-2015 Pfizer Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 72
Figure 2010-2015 Pfizer Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 73
Figure 2010-2015 Pfizer Active Pharmaceutical Ingredients Production Global Market Share 73
Table Bayer Company Profile 74
Table 2010-2015 Bayer Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 75
Figure 2010-2015 Bayer Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 75
Figure 2010-2015 Bayer Active Pharmaceutical Ingredients Production Global Market Share 76
Table BASF Company Profile 77
Table 2010-2015 BASF Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 77
Figure 2010-2015 BASF Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 78
Figure 2010-2015 BASF Active Pharmaceutical Ingredients Production Global Market Share 79
Table Cambrex Company Profile 80
Table 2010-2015 Cambrex Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 80
Figure 2010-2015 Cambrex Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 81
Figure 2010-2015 Cambrex Active Pharmaceutical Ingredients Production Global Market Share 81
Table Sun Pharmaceutical Company Profile 82
Table 2010-2015 Sun Pharmaceutical Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 83
Figure 2010-2015 Sun Pharmaceutical Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 84
Figure 2010-2015 Sun Pharmaceutical Active Pharmaceutical Ingredients Production Global Market Share 84
Table 2010-2015 Lonza group Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 86
Figure 2010-2015 Lonza group Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 86
Figure 2010-2015 Lonza group Active Pharmaceutical Ingredients Production Global Market Share 87
Table 2010-2015 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 88
Figure 2010-2015 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 88
Figure 2010-2015 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients Production Global Market Share 89
Table 2010-2015 Aurobindo pharma Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 90
Figure 2010-2015 Aurobindo pharma Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 91
Figure 2010-2015 Aurobindo pharma Active Pharmaceutical Ingredients Production Global Market Share 91
Table 2010-2015 Lupin Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 93
Figure 2010-2015 Lupin Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 93
Figure 2010-2015 Lupin Active Pharmaceutical Ingredients Production Global Market Share 94
Table 2010-2015 Biocon Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 96
Figure 2010-2015 Biocon Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 96
Figure 2010-2015 Biocon Active Pharmaceutical Ingredients Production Global Market Share 97
Table Cipla Company Profile 98
Table 2010-2015 Cipla Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 99
Figure 2010-2015 Cipla Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 99
Figure 2010-2015 Cipla Active Pharmaceutical Ingredients Production Global Market Share 100
Table Hisun Pharmacy Company Profile 100
Table 2010-2015 Hisun Pharmacy Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 101
Figure 2010-2015 Hisun Pharmacy Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 102
Figure 2010-2015 Hisun Pharmacy Active Pharmaceutical Ingredients Production Global Market Share 102
Table 2010-2015 Huahai Pharmaceutical Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 104
Figure 2010-2015 Huahai Pharmaceutical Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 104
Figure 2010-2015 Huahai Pharmaceutical Active Pharmaceutical Ingredients Production Global Market Share 105
Table 2010-2015 North China Pharmaceutical Group Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 106
Figure 2010-2015 North China Pharmaceutical Group Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 106
Figure 2010-2015 North China Pharmaceutical Group Active Pharmaceutical Ingredients Production Global Market Share 107
Table 2010-2015 Lukang Pharmaceutical Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 109
Figure 2010-2015 Lukang Pharmaceutical Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 109
Figure 2010-2015 Lukang Pharmaceutical Active Pharmaceutical Ingredients Production Global Market Share 110
Table 2010-2015 Haerbin Pharmaceutical Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 112
Figure 2010-2015 Haerbin Pharmaceutical Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 113
Figure 2010-2015 Haerbin Pharmaceutical Active Pharmaceutical Ingredients Production Global Market Share 113
Table 2010-2015 Xinhua Pharmaceutical Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 115
Figure 2010-2015 Xinhua Pharmaceutical Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 115
Figure 2010-2015 Xinhua Pharmaceutical Active Pharmaceutical Ingredients Production Global Market Share 116
Table 2010-2015 Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 117
Figure 2010-2015 Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 118
Figure 2010-2015 Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredients Production Global Market Share 118
Table 2010-2015 Tian Yao Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 120
Figure 2010-2015 Tian Yao Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 120
Figure 2010-2015 Tian Yao Active Pharmaceutical Ingredients Production Global Market Share 121
Table 2010-2015 North East Pharmaceutical Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 122
Figure 2010-2015 North East Pharmaceutical Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 123
Figure 2010-2015 North East Pharmaceutical Active Pharmaceutical Ingredients Production Global Market Share 123
Table 2010-2015 Zhejiang Medicine Active Pharmaceutical Ingredients Production (Ton) Price (USD/Ton) Cost Gross Production Value (Million USD) Gross Margin List 125
Figure 2010-2015 Zhejiang Medicine Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 126
Figure 2010-2015 Zhejiang Medicine Active Pharmaceutical Ingredients Production Global Market Share 126
Table 2010-2015 Major Manufacturers Price 128
Figure Global 2010-2015 Consumption 129
Table Global 2010-2015 Cross Margin 129
Table Different Countries Price Comparisons 130
Table Different Types Comparisons 130
Figure 2015-2020 Global Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 131
Table 2015-2020 Global Active Pharmaceutical Ingredients Capacity Production (Ton) and Growth Rate 131
Table 2015-2020 Global Active Pharmaceutical Ingredients Capacity Utilization Rate List 132
Figure 2015-2020 Global Active Pharmaceutical Ingredients Capacity Utilization Rate List 132
Figure 2015-2020 Global Active Pharmaceutical Ingredients Consumption (Ton) and Growth Rate 133
Table 2015-2020 Global Active Pharmaceutical Ingredients Production (Ton) Price Cost Gross (USD/Ton) Production Value (Million USD) Gross Margin List 134
Table Manufacturing Equipment Suppliers and Contact Information 135
Table Key Consumers and Their Contact Information 136
Figure Active Pharmaceutical Ingredients Supply Chain Relationship Analysis 137
Table Active Pharmaceutical Ingredients Project SWOT Analysis 138
Table 10000Ton/Year Active Pharmaceutical Ingredients Project Investment Feasibility and Investment Return Analysis 139

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.